On March 6, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that company management will participate and present at the following investors conferences in March (Press release, Iovance Biotherapeutics, MAR 6, 2019, View Source;p=irol-newsArticle&ID=2390295 [SID1234534023]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 39th Annual Health Care Conference in Boston, March 11-13, 2019
Location: Boston Marriott Copley Place
Date/Time: Wednesday, March 13, at 8:00 a.m. EDT
A live and archived webcast of the presentation will be available by visiting the Investors section of Iovance Biotherapeutics’ website at View Source

Oncology Investor Conference in Boston, March 14-15, 2019
Location: 28 State Street
Date/time: Thursday, March 14, at 3:30 p.m. EDT

Oppenheimer 29th Annual Healthcare Conference in New York, March 19-20, 2019
Location: The Westin New York Grand Central
Date/Time: Tuesday, March 19, at 8:00 a.m. EDT
A live and archived webcast of the presentation will be available by visiting the Investors section of Iovance Biotherapeutics’ website at View Source

Alliance for Regenerative Medicine (ARM) 7th Annual Cell & Gene Therapy Investor Day in New York on March 21, 2019
Location: The Metropolitan Club
Date/Time: Thursday, March 21, at 11:25 a.m. EDT

China Healthcare Investment Conference (CHIC) in Shanghai, China on March 26-28, 2019
Location: The Ritz-Carlton Shanghai, Pudong
Date/Time: Thursday, March 28, at 9:00 a.m. China Standard Time (CST)